Beaumont Financial Advisors, LLC Revolution Medicines, Inc. Transaction History
Beaumont Financial Advisors, LLC
- $1.14 Billion
- Q4 2024
A detailed history of Beaumont Financial Advisors, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Beaumont Financial Advisors, LLC holds 13,738 shares of RVMD stock, worth $546,772. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,738
Previous 14,924
7.95%
Holding current value
$546,772
Previous $676,000
11.24%
% of portfolio
0.05%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
296Shares Held
171MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$680 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$534 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$527 Million3.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$377 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY7.94MShares$316 Million3.85% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.49B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...